IQVIA Holdings, Inc. Common Stock (NY:IQV)

258.21 -2.51 (-0.96%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? ↗

February 06, 2025

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged...

Via Benzinga

Topics Stocks

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Analyst Expectations For IQVIA Hldgs's Future ↗

February 03, 2025

Via Benzinga

How Is The Market Feeling About IQVIA Hldgs? ↗

January 03, 2025

Via Benzinga

(IQV) - Analyzing IQVIA Hldgs's Short Interest ↗

November 20, 2024

Via Benzinga

Peering Into IQVIA Hldgs's Recent Short Interest ↗

November 05, 2024

Via Benzinga

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions ↗

February 06, 2025

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and solid R&DS bookings fuel confidence.

Via Benzinga

Gapping S&P500 stocks in Thursday's session ↗

February 06, 2025

Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session.

Via Chartmill

Wondering what's happening in today's S&P500 pre-market session? ↗

February 06, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars

February 06, 2025

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue...

Via StockStory

Looking Into IQVIA Hldgs's Recent Short Interest ↗

October 17, 2024

Via Benzinga

Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights ↗

October 08, 2024

Via Benzinga

How Is The Market Feeling About IQVIA Hldgs? ↗

October 01, 2024

Via Benzinga

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

February 06, 2025

From IQVIA Holdings Inc.

Via Business Wire

IQVIA (IQV) Q4 Earnings Report Preview: What To Look For

February 05, 2025

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

Via StockStory

IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

February 04, 2025

From IQVIA

Via Business Wire

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

January 21, 2025

From IQVIA

Via Business Wire

A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs ↗

September 20, 2024

Via Benzinga

Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier? ↗

January 14, 2025

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.

Via Benzinga

Topics Artificial Intelligence

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

January 13, 2025

From IQVIA

Via Business Wire

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

December 23, 2024

From IQVIA

Via Business Wire

Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3 ↗

November 14, 2024

Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel...

Via Benzinga

Topics Regulatory Compliance

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

November 06, 2024

From IQVIA Holdings Inc.

Via Business Wire

IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day

October 31, 2024

From IQVIA Holdings Inc.

Via Business Wire

IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024

October 15, 2024

From IQVIA Holdings Inc.

Via Business Wire

GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations ↗

October 10, 2024

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year.

Via Benzinga

IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™

October 02, 2024

From IQVIA

Via Business Wire

Four Stocks To Watch This Week - Tuesday, Oct. 01 ↗

October 01, 2024

A flat week that was anticipated, one notable event was China's stimulus package announcement, which sent China-related stocks soaring. Most of these stocks surged without prior consolidations/warning...

Via Talk Markets

Is Viking Therapeutics Stock a Buy? ↗

September 29, 2024

The company is in the spotlight for one of its programs, but it's got others that also have promise.

Via The Motley Fool

IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award

September 19, 2024

From IQVIA

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.